Orcosa
Orcosa Inc.
Orcosa is a clinical-stage pharmaceutical company developing medicines with RITe™, our proprietary tablet technology. Explore our company, pipeline and science.
orcosa.com · Ewing, NJ
Funding event
The round itself, as filedInferred stageSeries A
Sold of offered$6.0M of $11.5M
Filed2026-11-12
Days since filing1
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-07-15
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Bryan RidallExecutive Officer · Director
- Vincent MiletoExecutive Officer · Director
- Robert PollaroExecutive Officer · Director
Health flags
Three flags, each with the raw inputs behind it · as of 2026-11-13UndersubscribedNot flagged$6.0M of $11.5M sold4 months since first sale
Prior raiseNot flaggedRaised $6.0M against a prior $7.3M$7.3M prior raise, filed 2025-01-07
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-11-130
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-11-15ChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuietNanopathSeries B · $25.0M · Cambridge, MAQuiet
103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.